Effect of Vegetarien Diet on Protein Digestibility in Young and Elderly Volunteers

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

About this trial

Plant proteins are usually less digestible than animal proteins, but they may benefit gut health through effects on the microbiome. The long-term impact of diets rich in plant products on protein digestion and metabolism is still unknown, especially in older adults with higher protein needs. This study aims to compare the digestion and use of pea proteins in young and older adults, both vegetarians and omnivores. Volunteers are divided into four groups: young omnivores, young vegetarians, older omnivores, and older vegetarians. They take part in two clinical investigation days. On the first day, nitrogen retention and protein metabolism is measured after consumption of a pea-based meal. On the second day, amino acid digestibility of pea is evaluated. These results will provide valuable data on how plant proteins are digested and metabolized depending on age and diet. They will also help determine whether aging reduces the availability of plant proteins. This knowledge is important to support nutritional strategies for populations with specific protein needs, such as older adults.

Eligibility criteria

Qualifiers

Normal weight or overweight (18 < BMI < 30 kg·m-²)

Male or female

Aged 18-23 years (young groups) or 65-75 years (older groups)

Following an omnivorous diet (regular consumption of meat products, with meat intake > 3 times/week and > 70% of protein intake from animal sources) or vegetarian diet (exclusion of meat and fish/seafood, with > 70% of protein intake from plant sources)

Disqualifiers

Adults under legal protection or unable to give informed consent (e.g., under guardianship, trusteeship, or legal protection)

Any known food allergy

Positive serology for HBsAg, anti-HBc, HCV, or HIV

Anemia: hemoglobin level < 13 g/dL in men and < 12 g/dL in women

Trial design

Treatments tested in this trial

  • Postprandial test
  • Amino acid bioavailability

Treatment groups

48 Participants
are divided into 4 treatment groups